The “Build-to-Buy”Framework   Three parties are used: (a) a science company with a novel technology, (b) a venture capital firm and (c) a big pharma company.

First-in-man Somebody’s got to be the first, the pioneer, the risk taker.  Two publicly traded companies, Genvec (NASDAQ:GNVC) and its big pharma partner, Novartis (NYSE:NVS)

AUGUST 2018: Rescue Hearing Inc (RHI) has signed a Sponsored Research Agreement with the University of Kansas Medical Center Research Institute.  RHI will be conducting

July 18, 2018:  Rescue Hearing Inc (RHI) has signed a Sponsored Research Agreement with Massachusetts Eye and Ear.  RHI will be conducting research to develop